The Ukrainian Intellectual Property Institute (Ukrpatent) issued 239 patents for inventions and useful models in the processing industry in 2017, including 42 in the sphere of production of key pharmaceutical products and medicines, which is the largest figure in the past five years. Ukrpatent told Interfax-Ukraine that in 2016, Ukrpatent issued 29 patents to national producers in the sphere of pharmaceutical production, 10 in 2015, seven in 2014 and 19 in 2013.
In January-March 2018, Ukrpatent issued 61 patents for inventions and utility models in the processing industry, including five in production of basic pharmaceutical products and medicines. In the first quarter of 2016 and 2017 in the field of pharmaceutical production, 11 patents were issued, in 2014 – none, in 2014 – four.
At the same time, Ukrpatent told Interfax-Ukraine that “Ukrainian legislation in the field of protection of rights to utility models and industrial designs does not provide for a qualification examination, so sometimes unfair applicants apply for facilities that are already in the economic flow.”
Ukrpatent reminded that in Ukraine patents for industrial designs and utility models are issued using the declarative system, which does not provide for a qualification examination, which, in the institute’s opinion, corresponds to a fairly widespread international practice.
In this case, the qualification examination can either be conducted, or not conducted, or carried out under a shortened procedure. According to the institute, in 2017, Ukrpatent received 2,480 applications for industrial designs, 9,105 applications for utility models and 4,048 applications for inventions. At the same time, Ukrpatent said that the term “declarative patent” is currently absent in the legislation of Ukraine.
INSTITUTE, INTELLECTUAL PROPERTY, PATENTS, PHARMA PRODUCTION
